NTRK gene fusion testing and management in lung cancer

Authors: Repetto, Matteo, Chiara Garassino, Marina, Loong, Herbert H., Lopez-Rios, Fernando, Mok, Tony, Peters, Solange, Planchard, David, Popat, Sanjay, Rudzinski, Erin R., Drilon, Alexander, Zhou, Caicun

Source: In Cancer Treatment Reviews June 2024 127

Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem

Authors: Lo Russo, Giuseppe, Macerelli, Marianna, Platania, Marco, Zilembo, Nicoletta, Vitali, Milena, Signorelli, Diego, Proto, Claudia, Ganzinelli, Monica, Gallucci, Rosaria, Agustoni, Francesco, Fasola, Gianpiero, de Braud, Filippo, Chiara Garassino, Marina

Source: Current Drug Targets; March 2017, Vol. 18 Issue: 3 p341-362, 22p

Across the Universe of K-Ras Mutations in Non-Small-Cell-Lung Cancer

Authors: Piva, Sheila, Ganzinelli, Monica, Chiara Garassino, Marina, Caiola, Elisa, Farina, Gabriella, Broggini, Massimo, Marabese, Mirko

Source: Current Pharmaceutical Design; May 2014, Vol. 20 Issue: 24 p3933-3943, 11p

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).

Authors: Ganzinelli, Monica¹, Chiara Garassino, Marina¹, Cristina Locatelli, Maria², Bertolini, Alessandro³, Valmadre, Giuseppe⁴, Pavese, Ida⁵, Calcagno, Anna⁶, Giuseppa Sarobba, Maria⁷, Rulli, Eliana⁸, Caiola, Elisa⁸, Broggini, Massimo⁸, Copreni, Elena⁸, Marabese, Mirko⁸, Piva, Sheila⁸, Longo, Flavia⁸, Labianca, Roberto⁸, Bareggi, Claudia⁸, Agnese Fabbri, Maria⁸, Martelli, Olga⁸, Fagnani, Daniele⁸

Source: Scientific Reports. 11/20/2015, p16331. 1p.

Subject Terms: *MICRORNA, *NEOPLASTIC cell transformation, *NON-small-cell lung carcinoma, *ERLOTINIB, *PROGRESSION-free survival, *DOCETAXEL